Iniciar sesión
Headquarters
Japan

Takeda Pharmaceutical

Takeda (TSE:4502/NYSE:TAK), a global values-based R&D-driven biopharmaceutical leader headquartered in Japan, translates science into innovative medicines. It focuses its R&D efforts on four therapeutic areas: oncology, rare diseases, neuroscience and gastroenterology. It also makes R&D investments in plasma-derived therapies and vaccines. Takeda is focusing on developing innovative medicines that contribute to making a difference in people's lives by advancing the frontier of new treatment options and leveraging enhanced collaborative R&D engines and capabilities to create a modality-diverse pipeline. Its employees are committed to improving quality of life for patients and to working with healthcare partners in some 80 countries.

Visite el sitio web de Takeda Pharmaceutical

Suscribirse a las actualizaciones

Una actualización semanal de lo que hay en la Agenda Global

© 2021 World Economic Forum

Política de privacidad y normas de uso